IPD Analytics Revenue and Competitors

Miami, USA

Location

N/A

Total Funding

Technology

Industry

Estimated Revenue & Valuation

  • IPD Analytics's estimated annual revenue is currently $53.8M per year.(i)
  • IPD Analytics's estimated revenue per employee is $222,200

Employee Data

  • IPD Analytics has 242 Employees.(i)
  • IPD Analytics grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7330M351780%$22.1M$5.1B
Add Company

IPD Analytics provides syndicated solutions that combine proprietary analysis and well-researched data to forecast new product entry, loss of exclusivity, and other competitive factors impacting product positioning and life cycles within the healthcare and technology sectors. Subscribers of IPD Analytics streamline commercial evaluation processes by gaining unmatched visibility into projected shifts in the competitive landscape. Such visibility has supported investment, forecasting, procurement, and formulary decisions for our subscribers since 2002. IPD Analytics utilizes a unique combination of legal, clinical, and managed care expertise to conduct deep fundamental research and to develop industry-leading life-cycle insights. Investment firms and pharmaceutical manufacturers use IPD's syndicated solutions to better understand how legal outcomes, regulatory decisions, and payor strategy will impact competitive positioning. IPD's comprehensive analysis allows subscribers to conduct such evaluations easily at the product, company, and disease level. Members of the managed-care, hospital, and supply-chain industries utilize IPD's clinical intelligence and management strategies to support contracting, procurement, inventory management, and formulary decisions. Reach out to learn more! www.ipdanalytics.com I 305.662.8515 I info@ipdanalytics.com

keywords:N/A

N/A

Total Funding

242

Number of Employees

$53.8M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

IPD Analytics News

2022-04-13 - Oncology Biosimilars Enter an Era of Expansion

IPD Analytics. October 14, 2021. Accessed November 23, 2021. https://www.ipdanalytics.com/lifecycleinsights. 8. Biomedtracker.

2022-03-30 - Jeffery Casberg Previews His Presentations at AMCP 2022

Jeffrey Casberg, vice president of pharmacy at IPD Analytics, previews his sessions about the new and emerging pharmaceutical proucts coming...

2022-03-22 - Data, Disparities, Drug Pricing Take Center Stage at AMCP ...

Jeffrey Casberg, MS, RPh, and Leslie Fish, RPh, PharmD, both of IPD Analytics, LLC, will present 2 sessions on the drug pipeline.